3 ASX Stocks That Could Be Trading At A Discount For Savvy Investors

In This Article:

The Australian stock market has been experiencing a remarkable upswing, with the ASX200 closing at a new record high and showing a significant 19% increase over the past year. Amidst this strong performance, identifying stocks that may be trading at a discount can offer potential opportunities for investors seeking value in an otherwise buoyant market environment.

Top 10 Undervalued Stocks Based On Cash Flows In Australia

Name

Current Price

Fair Value (Est)

Discount (Est)

Accent Group (ASX:AX1)

A$2.55

A$4.92

48.2%

DUG Technology (ASX:DUG)

A$1.75

A$3.36

47.9%

MLG Oz (ASX:MLG)

A$0.64

A$1.17

45.2%

Ingenia Communities Group (ASX:INA)

A$5.03

A$9.24

45.6%

Genesis Minerals (ASX:GMD)

A$2.43

A$4.82

49.6%

Millennium Services Group (ASX:MIL)

A$1.145

A$2.24

48.9%

Vault Minerals (ASX:VAU)

A$0.34

A$0.65

47.8%

Gold Road Resources (ASX:GOR)

A$2.00

A$3.65

45.2%

Energy One (ASX:EOL)

A$5.30

A$10.56

49.8%

FINEOS Corporation Holdings (ASX:FCL)

A$1.915

A$3.75

48.9%

Click here to see the full list of 37 stocks from our Undervalued ASX Stocks Based On Cash Flows screener.

Below we spotlight a couple of our favorites from our exclusive screener.

Gold Road Resources

Overview: Gold Road Resources Limited, along with its subsidiaries, is involved in the exploration of gold properties in Western Australia and has a market capitalization of approximately A$2.21 billion.

Operations: The company generates revenue primarily from its Development and Production segment, amounting to A$454.82 million.

Estimated Discount To Fair Value: 45.2%

Gold Road Resources is trading at A$2, significantly below its estimated fair value of A$3.65, suggesting it might be undervalued based on cash flows. The company's earnings are expected to grow 20.8% annually over the next three years, outpacing the Australian market's growth rate of 12.6%. However, its forecasted Return on Equity remains modest at 13.2%. Recent M&A discussions involving Gold Road highlight potential strategic opportunities in the gold sector.

ASX:GOR Discounted Cash Flow as at Dec 2024
ASX:GOR Discounted Cash Flow as at Dec 2024

PolyNovo

Overview: PolyNovo Limited designs, manufactures, and sells biodegradable medical devices in the United States, Australia, New Zealand, and internationally with a market cap of A$1.51 billion.

Operations: The company's revenue is primarily generated from the development, manufacturing, and commercialization of the NovoSorb Technology, amounting to A$103.23 million.

Estimated Discount To Fair Value: 25.6%